Literature DB >> 34750568

The addiction risk factor: A unitary genetic vulnerability characterizes substance use disorders and their associations with common correlates.

Ryan Bogdan1, Arpana Agrawal2, Alexander S Hatoum3, Emma C Johnson2, Sarah M C Colbert2, Renato Polimanti4,5, Hang Zhou4,5, Raymond K Walters6,7, Joel Gelernter4,5,8,9, Howard J Edenberg10,11.   

Abstract

Substance use disorders commonly co-occur with one another and with other psychiatric disorders. They share common features including high impulsivity, negative affect, and lower executive function. We tested whether a common genetic factor undergirds liability to problematic alcohol use (PAU), problematic tobacco use (PTU), cannabis use disorder (CUD), and opioid use disorder (OUD) by applying genomic structural equation modeling to genome-wide association study summary statistics for individuals of European ancestry (Total N = 1,019,521; substance-specific Ns range: 82,707-435,563) while adjusting for the genetics of substance use (Ns = 184,765-632,802). We also tested whether shared liability across SUDs is associated with behavioral constructs (risk-taking, executive function, neuroticism; Ns = 328,339-427,037) and non-substance use psychopathology (psychotic, compulsive, and early neurodevelopmental disorders). Shared genetic liability to PAU, PTU, CUD, and OUD was characterized by a unidimensional addiction risk factor (termed The Addiction-Risk-Factor, independent of substance use. OUD and CUD demonstrated the largest loadings, while problematic tobacco use showed the lowest loading. The Addiction-Risk-Factor was associated with risk-taking, neuroticism, executive function, and non-substance psychopathology, but retained specific variance before and after accounting for the genetics of substance use. Thus, a common genetic factor partly explains susceptibility for alcohol, tobacco, cannabis, and opioid use disorder. The Addiction-Risk-Factor has a unique genetic architecture that is not shared with normative substance use or non-substance psychopathology, suggesting that addiction is not the linear combination of substance use and psychopathology.
© 2021. The Author(s), under exclusive licence to American College of Neuropsychopharmacology.

Entities:  

Mesh:

Year:  2021        PMID: 34750568      PMCID: PMC9372072          DOI: 10.1038/s41386-021-01209-w

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   8.294


  41 in total

1.  Genetic etiology of the common liability to drug dependence: evidence of common and specific mechanisms for DSM-IV dependence symptoms.

Authors:  Rohan H C Palmer; Tanya M Button; Soo H Rhee; Robin P Corley; Susan E Young; Michael C Stallings; Christian J Hopfer; John K Hewitt
Journal:  Drug Alcohol Depend       Date:  2012-01-11       Impact factor: 4.492

2.  A latent class analysis of DSM-IV and Fagerström (FTND) criteria for nicotine dependence.

Authors:  Arpana Agrawal; Jeffrey F Scherrer; Michele L Pergadia; Michael T Lynskey; Pamela A F Madden; Carolyn E Sartor; Julia D Grant; Alexis E Duncan; Jon R Haber; Theodore Jacob; Kathleen K Bucholz; Hong Xian
Journal:  Nicotine Tob Res       Date:  2011-07-21       Impact factor: 4.244

3.  Revealing the complex genetic architecture of obsessive-compulsive disorder using meta-analysis.

Authors: 
Journal:  Mol Psychiatry       Date:  2017-08-01       Impact factor: 15.992

4.  Interrogating the Genetic Determinants of Tourette's Syndrome and Other Tic Disorders Through Genome-Wide Association Studies.

Authors:  Dongmei Yu; Jae Hoon Sul; Fotis Tsetsos; Muhammad S Nawaz; Alden Y Huang; Ivette Zelaya; Cornelia Illmann; Lisa Osiecki; Sabrina M Darrow; Matthew E Hirschtritt; Erica Greenberg; Kirsten R Muller-Vahl; Manfred Stuhrmann; Yves Dion; Guy Rouleau; Harald Aschauer; Mara Stamenkovic; Monika Schlögelhofer; Paul Sandor; Cathy L Barr; Marco Grados; Harvey S Singer; Markus M Nöthen; Johannes Hebebrand; Anke Hinney; Robert A King; Thomas V Fernandez; Csaba Barta; Zsanett Tarnok; Peter Nagy; Christel Depienne; Yulia Worbe; Andreas Hartmann; Cathy L Budman; Renata Rizzo; Gholson J Lyon; William M McMahon; James R Batterson; Danielle C Cath; Irene A Malaty; Michael S Okun; Cheston Berlin; Douglas W Woods; Paul C Lee; Joseph Jankovic; Mary M Robertson; Donald L Gilbert; Lawrence W Brown; Barbara J Coffey; Andrea Dietrich; Pieter J Hoekstra; Samuel Kuperman; Samuel H Zinner; Pétur Luðvigsson; Evald Sæmundsen; Ólafur Thorarensen; Gil Atzmon; Nir Barzilai; Michael Wagner; Rainald Moessner; Roel Ophoff; Carlos N Pato; Michele T Pato; James A Knowles; Joshua L Roffman; Jordan W Smoller; Randy L Buckner; A Jeremy Willsey; Jay A Tischfield; Gary A Heiman; Hreinn Stefansson; Kári Stefansson; Danielle Posthuma; Nancy J Cox; David L Pauls; Nelson B Freimer; Benjamin M Neale; Lea K Davis; Peristera Paschou; Giovanni Coppola; Carol A Mathews; Jeremiah M Scharf
Journal:  Am J Psychiatry       Date:  2019-03-01       Impact factor: 18.112

5.  Discovery of the first genome-wide significant risk loci for attention deficit/hyperactivity disorder.

Authors:  Ditte Demontis; Raymond K Walters; Joanna Martin; Manuel Mattheisen; Thomas D Als; Esben Agerbo; Gísli Baldursson; Rich Belliveau; Jonas Bybjerg-Grauholm; Marie Bækvad-Hansen; Felecia Cerrato; Kimberly Chambert; Claire Churchhouse; Ashley Dumont; Nicholas Eriksson; Michael Gandal; Jacqueline I Goldstein; Katrina L Grasby; Jakob Grove; Olafur O Gudmundsson; Christine S Hansen; Mads Engel Hauberg; Mads V Hollegaard; Daniel P Howrigan; Hailiang Huang; Julian B Maller; Alicia R Martin; Nicholas G Martin; Jennifer Moran; Jonatan Pallesen; Duncan S Palmer; Carsten Bøcker Pedersen; Marianne Giørtz Pedersen; Timothy Poterba; Jesper Buchhave Poulsen; Stephan Ripke; Elise B Robinson; F Kyle Satterstrom; Hreinn Stefansson; Christine Stevens; Patrick Turley; G Bragi Walters; Hyejung Won; Margaret J Wright; Ole A Andreassen; Philip Asherson; Christie L Burton; Dorret I Boomsma; Bru Cormand; Søren Dalsgaard; Barbara Franke; Joel Gelernter; Daniel Geschwind; Hakon Hakonarson; Jan Haavik; Henry R Kranzler; Jonna Kuntsi; Kate Langley; Klaus-Peter Lesch; Christel Middeldorp; Andreas Reif; Luis Augusto Rohde; Panos Roussos; Russell Schachar; Pamela Sklar; Edmund J S Sonuga-Barke; Patrick F Sullivan; Anita Thapar; Joyce Y Tung; Irwin D Waldman; Sarah E Medland; Kari Stefansson; Merete Nordentoft; David M Hougaard; Thomas Werge; Ole Mors; Preben Bo Mortensen; Mark J Daly; Stephen V Faraone; Anders D Børglum; Benjamin M Neale
Journal:  Nat Genet       Date:  2018-11-26       Impact factor: 38.330

6.  Item-Level Genome-Wide Association Study of the Alcohol Use Disorders Identification Test in Three Population-Based Cohorts.

Authors:  Travis T Mallard; Jeanne E Savage; Emma C Johnson; Yuye Huang; Alexis C Edwards; Jouke J Hottenga; Andrew D Grotzinger; Daniel E Gustavson; Mariela V Jennings; Andrey Anokhin; Danielle M Dick; Howard J Edenberg; John R Kramer; Dongbing Lai; Jacquelyn L Meyers; Ashwini K Pandey; Kathryn Paige Harden; Michel G Nivard; Eco J C de Geus; Dorret I Boomsma; Arpana Agrawal; Lea K Davis; Toni-Kim Clarke; Abraham A Palmer; Sandra Sanchez-Roige
Journal:  Am J Psychiatry       Date:  2021-05-14       Impact factor: 19.242

7.  Genome-wide association study of alcohol consumption and use disorder in 274,424 individuals from multiple populations.

Authors:  Henry R Kranzler; Hang Zhou; Rachel L Kember; Rachel Vickers Smith; Amy C Justice; Scott Damrauer; Philip S Tsao; Derek Klarin; Aris Baras; Jeffrey Reid; John Overton; Daniel J Rader; Zhongshan Cheng; Janet P Tate; William C Becker; John Concato; Ke Xu; Renato Polimanti; Hongyu Zhao; Joel Gelernter
Journal:  Nat Commun       Date:  2019-04-02       Impact factor: 14.919

8.  Identification of common genetic risk variants for autism spectrum disorder.

Authors:  Jakob Grove; Stephan Ripke; Thomas D Als; Manuel Mattheisen; Raymond K Walters; Hyejung Won; Jonatan Pallesen; Esben Agerbo; Ole A Andreassen; Richard Anney; Swapnil Awashti; Rich Belliveau; Francesco Bettella; Joseph D Buxbaum; Jonas Bybjerg-Grauholm; Marie Bækvad-Hansen; Felecia Cerrato; Kimberly Chambert; Jane H Christensen; Claire Churchhouse; Karin Dellenvall; Ditte Demontis; Silvia De Rubeis; Bernie Devlin; Srdjan Djurovic; Ashley L Dumont; Jacqueline I Goldstein; Christine S Hansen; Mads Engel Hauberg; Mads V Hollegaard; Sigrun Hope; Daniel P Howrigan; Hailiang Huang; Christina M Hultman; Lambertus Klei; Julian Maller; Joanna Martin; Alicia R Martin; Jennifer L Moran; Mette Nyegaard; Terje Nærland; Duncan S Palmer; Aarno Palotie; Carsten Bøcker Pedersen; Marianne Giørtz Pedersen; Timothy dPoterba; Jesper Buchhave Poulsen; Beate St Pourcain; Per Qvist; Karola Rehnström; Abraham Reichenberg; Jennifer Reichert; Elise B Robinson; Kathryn Roeder; Panos Roussos; Evald Saemundsen; Sven Sandin; F Kyle Satterstrom; George Davey Smith; Hreinn Stefansson; Stacy Steinberg; Christine R Stevens; Patrick F Sullivan; Patrick Turley; G Bragi Walters; Xinyi Xu; Kari Stefansson; Daniel H Geschwind; Merete Nordentoft; David M Hougaard; Thomas Werge; Ole Mors; Preben Bo Mortensen; Benjamin M Neale; Mark J Daly; Anders D Børglum
Journal:  Nat Genet       Date:  2019-02-25       Impact factor: 38.330

9.  Biological insights from 108 schizophrenia-associated genetic loci.

Authors: 
Journal:  Nature       Date:  2014-07-22       Impact factor: 49.962

10.  Associations between Polygenic Risk for Psychiatric Disorders and Substance Involvement.

Authors:  Caitlin E Carey; Arpana Agrawal; Kathleen K Bucholz; Sarah M Hartz; Michael T Lynskey; Elliot C Nelson; Laura J Bierut; Ryan Bogdan
Journal:  Front Genet       Date:  2016-08-15       Impact factor: 4.599

View more
  8 in total

1.  Exploring the genetic overlap of suicide-related behaviors and substance use disorders.

Authors:  Sarah M C Colbert; Alexander S Hatoum; Andrey Shabalin; Qingqin S Li; Hilary Coon; Elliot C Nelson; Arpana Agrawal; Anna R Docherty; Emma C Johnson
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2021-11-25       Impact factor: 3.568

2.  Associations between cognition and polygenic liability to substance involvement in middle childhood: Results from the ABCD study.

Authors:  Sarah E Paul; Alexander S Hatoum; Deanna M Barch; Wesley K Thompson; Arpana Agrawal; Ryan Bogdan; Emma C Johnson
Journal:  Drug Alcohol Depend       Date:  2022-01-10       Impact factor: 4.852

3.  Crossing diagnostic boundaries to understand the genetic etiology of addiction.

Authors:  Travis T Mallard
Journal:  Neuropsychopharmacology       Date:  2021-12-06       Impact factor: 8.294

4.  Genetic liability for substance use associated with medical comorbidities in electronic health records of African- and European-ancestry individuals.

Authors:  Emily E Hartwell; Alison K Merikangas; Shefali S Verma; Marylyn D Ritchie; Henry R Kranzler; Rachel L Kember
Journal:  Addict Biol       Date:  2021-10-05       Impact factor: 4.093

5.  Altered expression of somatostatin signaling molecules and clock genes in the hippocampus of subjects with substance use disorder.

Authors:  Jake Valeri; Sinead M O'Donovan; Wei Wang; David Sinclair; Ratna Bollavarapu; Barbara Gisabella; Donna Platt; Craig Stockmeier; Harry Pantazopoulos
Journal:  Front Neurosci       Date:  2022-09-07       Impact factor: 5.152

6.  Parsing genetically influenced risk pathways: genetic loci impact problematic alcohol use via externalizing and specific risk.

Authors:  Peter B Barr; Travis T Mallard; Sandra Sanchez-Roige; Holly E Poore; Richard Karlsson Linnér; Irwin D Waldman; Abraham A Palmer; K Paige Harden; Danielle M Dick
Journal:  Transl Psychiatry       Date:  2022-09-30       Impact factor: 7.989

7.  Pairwise genetic meta-analyses between schizophrenia and substance dependence phenotypes reveals novel association signals with pharmacological significance.

Authors:  Laura A Greco; William R Reay; Christopher V Dayas; Murray J Cairns
Journal:  Transl Psychiatry       Date:  2022-09-23       Impact factor: 7.989

8.  Investigation of convergent and divergent genetic influences underlying schizophrenia and alcohol use disorder.

Authors:  Emma C Johnson; Manav Kapoor; Alexander S Hatoum; Hang Zhou; Renato Polimanti; Frank R Wendt; Raymond K Walters; Dongbing Lai; Rachel L Kember; Sarah Hartz; Jacquelyn L Meyers; Roseann E Peterson; Stephan Ripke; Tim B Bigdeli; Ayman H Fanous; Carlos N Pato; Michele T Pato; Alison M Goate; Henry R Kranzler; Michael C O'Donovan; James T R Walters; Joel Gelernter; Howard J Edenberg; Arpana Agrawal
Journal:  Psychol Med       Date:  2021-07-07       Impact factor: 10.592

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.